Columbia Laboratories to Present At UBS Warburg Global Specialty Pharmaceuticals Conference.Business Editors LIVINGSTON, N.J.--(BUSINESS WIRE)--May 21, 2003 Columbia Laboratories (AMEX AMEX See: American Stock Exchange : COB) announced today that Fred Wilkinson, president and chief executive officer, will present at the UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Warburg Global Specialty Pharmaceuticals Conference on June 4, 2003 at 4:00 p.m. Eastern Time at the Grand Hyatt New York Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The presentation will be webcast live, then archived and available 3 hours after the presentation ends for 15 days. The audio webcast can be accessed at: http://event.streamx.us/event/Default.asp?Event=UBS20030604. Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of women's health care and endocrinology products, including those intended to treat infertility, dysmenorrhea dysmenorrhea Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur. , endometriosis and hormonal deficiencies. Columbia is also developing hormonal products for men and a buccal delivery system for peptides. Columbia's products primarily utilize the company's patented Bioadhesive Delivery System (BDS BDS abbr. Bachelor of Dental Surgery BDS Bachelor of Dental Surgery BDS n abbr (= Bachelor of Dental Surgery) → tÃtulo universitario BDS ) technology. For more information, visit www.columbialabs.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion